Multicenter cohort analysis of anoikis and EMT: implications for prognosis and therapy in lung adenocarcinoma
The AEOM provides a robust prognostic model for LUAD, uncovering critical immune and biological pathways, with RHPN2 identified as a key oncogenic driver. These findings offer valuable insights for targeted therapies and enhanced patient outcomes.
Authors
- Lu Yin (ORCID: https://orcid.org/0000-0001-7607-3351)
- Zhanshuo Zhang
- Qiuyue Yan
- Yan Zhu (ORCID: https://orcid.org/0000-0002-6932-7971)
Institutions
- Nanjing Normal University (CN)
- Tianjin Medical University Cancer Institute and Hospital (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2024-09-19
- DOI
- https://doi.org/10.1007/s12672-024-01293-6
- Citations
- 2
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.84